Aker BioMarine ASA Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	218.1	199	196.3	277.2	262.1
Revenue	218.1	199	196.3	277.2	262.1
Revenue Growth (YoY)	9.60%	1.38%	-29.18%	5.76%	-9.18%
Cost of Revenue	120.3	120.6	123.8	162.4	174
Gross Profit	97.8	78.4	72.5	114.8	88.1
Selling, General & Admin	69.1	68	66.4	86.5	84.3
Other Operating Expenses	-2	-1	0.1	-4.4	-2.7
Operating Expenses	85	82.4	82.8	98.5	95
Operating Income	12.8	-4	-10.3	16.3	-6.9
Interest Expense	-13.9	-2.5	-19.7	-20.3	-13.7
Interest & Investment Income	1	3.6	1.5	0.6	-
Earnings From Equity Investments	-2.4	-	-3	-	-
Currency Exchange Gain (Loss)	1.1	-1	-0.8	8.1	0.6
Other Non Operating Income (Expenses)	-1.3	-8.1	-	-1.7	-1.7
EBT Excluding Unusual Items	-2.7	-12	-32.3	3	-21.7
Gain (Loss) on Sale of Assets	-	-	-	-	0.4
Asset Writedown	-0.1	-1.2	-	-	-5.8
Other Unusual Items	-	-	-	9.2	19.7
Pretax Income	-2.8	-12.1	-32.3	12.2	-7.4
Income Tax Expense	-	-0.1	-	2.2	0.6
Earnings From Continuing Operations	-2.8	-12	-32.3	10	-8
Earnings From Discontinued Operations	-20	194.6	23.3	-	-
Net Income	-22.8	182.6	-9	10	-8
Net Income to Common	-22.8	182.6	-9	10	-8
Shares Outstanding (Basic)	88	88	88	88	88
Shares Outstanding (Diluted)	88	88	88	88	88
Shares Change (YoY)	0.02%	0.02%	0.04%	0.05%	12.20%
EPS (Basic)	-0.26	2.08	-0.10	0.11	-0.09
EPS (Diluted)	-0.26	2.08	-0.10	0.11	-0.09
Free Cash Flow	-2.1	-5.2	1.5	-25.4	-76.1
Free Cash Flow Per Share	-0.02	-0.06	0.02	-0.29	-0.87
Gross Margin	44.84%	39.40%	36.93%	41.41%	33.61%
Operating Margin	5.87%	-2.01%	-5.25%	5.88%	-2.63%
Profit Margin	-10.45%	91.76%	-4.58%	3.61%	-3.05%
Free Cash Flow Margin	-0.96%	-2.61%	0.76%	-9.16%	-29.04%
EBITDA	34.3	37.1	10.4	61.1	38.5
EBITDA Margin	15.73%	18.64%	5.30%	22.04%	14.69%
D&A For EBITDA	21.5	41.1	20.7	44.8	45.4
EBIT	12.8	-4	-10.3	16.3	-6.9
EBIT Margin	5.87%	-2.01%	-5.25%	5.88%	-2.63%
Effective Tax Rate	-	-	-	18.03%	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.